This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Qbd (Qs-IP) Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Christopher Robert James Claxton: Innovator in Blood Compatibility Testing
Introduction
Christopher Robert James Claxton is a notable inventor based in Midlothian, GB. He has made significant contributions to the field of blood compatibility testing, particularly through his innovative methods for detecting blood group antibodies. His work is crucial for ensuring safe blood transfusions.
Latest Patents
Claxton holds a patent for a method titled "Crossmatching blood samples." This invention provides novel techniques for the detection of antibodies, specifically blood group antibodies. The methods developed by Claxton can be applied to pre-transfusion blood compatibility testing, helping to identify incompatibilities between donor units and recipients.
Career Highlights
Throughout his career, Claxton has worked with various companies, including QBD (Qs-IP) Limited and QBD Limited. His experience in these organizations has allowed him to refine his skills and contribute to advancements in medical technology.
Collaborations
Claxton has collaborated with notable individuals in his field, including David Cooper Robson and Neil Renault. These partnerships have facilitated the exchange of ideas and fostered innovation in blood compatibility testing.
Conclusion
Christopher Robert James Claxton is a distinguished inventor whose work in blood compatibility testing has the potential to save lives. His innovative methods and collaborations highlight the importance of advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile